Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp82 | Diabetes Epidemiology | ECE2018

Maternal exposure to air pollutants and risk of gestational diabetes mellitus in Taiwan

Shen Hsiu-Nien , Hua Sheng-Yuan , Chiu Chang-Ta , Li Chung-Yi

Objective: Mounting evidence has shown an increased risk of gestational diabetes mellitus (GDM) in association with elevated exposure to air pollution. However, limited evidence is available concerning the effect of specific air pollutant(s) on GDM incidence.Methods: We conducted this case-control study on 6717 mothers with GDM diagnosed in 2006–2013 and 6717 age- and year of delivery-matched controls to further address the risk of GDM in relation t...

ea0056p501 | Diabetes therapy | ECE2018

Comparison of occurrence of fasting hyperinsulinemia according to type of insulin analogs

Ahn Kyu Jeung , Kang Hyoseok , Cho In-Jin , Hwang You-Cheol , Jeong In-Kyung , Chung Ho-Yeon

Background: A variety of insulin analogs have been developed and used for the treatment of diabetes mellitus. We often experience elevated serum insulin levels when insulin analog is used, and thus have difficulty in assessing insulin resistance and secretion using serum insulin results. This study aimed to investigate the differences in serum fasting insulin level and insulin antibodies according to the type of insulin analogs.Method: We conducted a ret...

ea0056p574 | Obesity | ECE2018

Novel indicator of abdominal obesity strongly associated with cardiovascular disease

Kim Dong Sun , Park Jung Hwan , Ryu Ohk-Hyun , Chung Wankyo , Moon Shinje

Obesity is one of the leading causes of elevated cardiovascular disease (CVD) mortality and morbidity. Several indicators of abdominal obesity such as body mass index (BMI) and waist circumference (WC) are available. BMI and WC have limitations in stratifying cardio-metabolic risks. Another obesity measure, A Body Shape Index (ABSI), has been introduced but its applicability remains limited. To address this, the z-score of the log-transformed ABSI (LBSIZ) was recently develope...

ea0092ps1-08-04 | Translational 1 | ETA2023

Association between BMI and Brafv600E mutation status may differ by primary tumor size

Park Hyunju , Heo Jung , Jin Ryu Hyun , Hyuk Kim Tae , Wook Kim Sun , Hoon Chung Jae

Introduction: The prevalence of B-type Raf kinase (BRAFV600E) mutation in PTC has been observed in 30% to over 80%, and it seems that the mutation occurred in the early stage of thyroid carcinoma progression which precedes histological change. Based on previous reports, high body mass index (BMI) is considered a thyroid cancer risk. However, it is unclear whether high BMI has a certain association with the BRAFV600E mutational status. We assess whether high BMI is associated w...

ea0092ps3-22-01 | Nodules 2 | ETA2023

Radiofrequency ablation of benign thyroid nodules: Value of the anterolateral hydrodissection technique

Yeong Jeong So , Baek Jung Hwan , Rom Chung Sae , Jun Choi Young , Hyun Lee Jeong

Purpose: To evaluate the technical feasibility, efficacy, and safety of the anterolateral hydrodissection (ALHD) technique in radiofrequency ablation (RFA) for benign thyroid nodules.Methods: Between November 2019 and April 2020, 39 patients underwent 41 sessions of RFA with ALHD technique for treatment of benign thyroid nodules. ALHD was performed with cold (0°C–4°C) 5% dextrose solution during RFA to minimize pain and secure sufficient s...

ea0094p188 | Bone and Calcium | SFEBES2023

A clinical audit on pre-operative work up and post-operative follow up in patients undergoing surgical management for primary hyperparathyroidism in a large tertiary Centre in the United Kingdom

Wijewickrama Piyumi , Simpson Helen , Baldeweg Stephanie , Srirangalingam Umasuthan , Abdel-Aziz Tarek , Kurzawinski Tom , Chung Teng-Teng

Background: Primary hyperparathyroidism (PHPT) is a common endocrine disorder. Aim of this audit was to assess clinical, biochemical parameters, localisation modalities and outcome in patients undergoing parathyroidectomy at University College London Hospital (UCLH).Methods: We audited all patients aged 15-years or above, undergoing parathyroidectomy, from 01-02-2018 to 31-12-2021 at UCLH via retrospective data collectio...

ea0094p68 | Metabolism, Obesity and Diabetes | SFEBES2023

Investigating the pancreas-projecting enteric neurons in the regulation of metabolic homeostasis

Liu Jieruo , Meyer Leah , Chung Pei-En , Tao Yuxuan , Owen Bryn , Murphy Kevin

The regulation of insulin and glucagon secretion has traditionally been attributed to the gut-brain axis and direct sensing of blood glucose levels by pancreatic islets. However, the enteric nervous system may directly modulate pancreatic hormone release. This study focuses on a specific population of enteric neurons that exhibit the capability to transmit signals from the gut to the pancreas, potentially revealing new pathways of metabolic regulation. The gastrointestinal tra...

ea0099ep23 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

3-year setmelanotide weight outcomes in patients with bardet-biedl syndrome and obesity

Yanovski Jack , Angel Martos-Moreno Gabriel , Malhotra Sonali , Yuan Guojun , Chung Wendy , Dollfus Helene , Clement Karine

Background: Bardet-Biedl Syndrome (BBS) is a rare genetic disease in which impaired melanocortin-4 receptor (MC4R) signaling leads to hyperphagia and obesity. In an index Phase 3 trial, broad clinical benefit was observed in patients with BBS based on improvement or stabilization in ≥1 measure of weight, hunger, or quality of life with 1 year of treatment with the MC4R agonist setmelanotide. Reported here are long-term extension (LTE) weight outcomes after 3 years of set...

ea0099ep57 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Impact of setmelanotide on metabolic syndrome risk in patients with POMC and LEPR deficiency

Wabitsch Martin , Chung Wendy , Kuhnen Peter , Swain James , Garrison Jill , Touchot Nicolas , Argente Jesus , Clement Karine

Background: Proopiomelanocortin (POMC; including biallelic variants in PCSK1) and leptin receptor (LEPR) deficiency are associated with hyperphagia and early-onset, severe obesity. Treatment with the melanocortin-4 receptor agonist setmelanotide for 1 year results in significant and sustained improvements in weight (POMC, −25.6%; LEPR, −12.5%), hunger, and quality of life. We used the metabolic syndrome Z score based on body mass index (MetS-Z-BMI) to asse...

ea0070aep1069 | Hot topics (including COVID-19) | ECE2020

The role of growth hormone device optimisation in patient-reported outcomes: Real-world evidence from South Korea

Lee Ji-Eun , Lee Kee-Hyoung , Park Mi Jung , Yang Seung , Young Kim Eun , Rhie Young-Jun , Jung Min-Ho , Yang Aram , Kim Shin-Hye , Yoojin Chung Lindsey , Young Ko Su , Ju Lee Young , Nedjatian Navid , Yeong Chung Woo

Growth hormone (GH) therapy (GHT) requires long-term commitment to daily sc GH injections that may present adherence challenges. Patient preference and adherence have been shown to be affected by delivery devices in association with convenience of administration, level of injection-site pain, confidence in correct dose administration and satisfaction with the device. This survey investigated if switching GH device – from NordiLet/others to NordiFlex – improved pati...